INvestor Information

Read Our
Latest News

Leading the Future of Healthcare with Strategic Acquisitions and Pioneering Solutions

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

September 26, 2024
2024
Copied...

BROOKLYN, N.Y., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 25,300,000 units, which includes 3,300,000...

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

August 12, 2024
2024
Copied...

BROOKLYN, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) today announced that it closed its initial public offering of 25,300,000 units at $10.00 per unit, including the issuance of 3,300,000...

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

August 08, 2024
2024
Copied...

BROOKLYN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) announced today the pricing of its initial public offering of 22,000,000...

Please fill out the form below to receive company press releases via email when they occur.

Choose Notifications

Sec Filings
Company Information
Filing Date
Filing Type
Description
Document
March 31, 2025
2025
10-K
10-K

Annual report [Section 13 and 15(d), not S-K Item 405]

Annual Reports

March 21, 2025
2025
SCHEDULE 13G/A
SCHEDULE 13G/A

Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendment

February 14, 2025
2025
schedule-13g
schedule-13g

Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities

February 7, 2025
2025
SCHEDULE 13G
SCHEDULE 13G

Current report

February 6, 2025
2025
SCHEDULE 13G
SCHEDULE 13G

Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities

January 29, 2025
2025
SCHEDULE 13G/A
SCHEDULE 13G/A

Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendment

January 13, 2025
2025
SCHEDULE 13G/A
SCHEDULE 13G/A

Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendment

November 14, 2024
2024
SC 13G
SC 13G

Statement of acquisition of beneficial ownership by individuals

November 14, 2024
2024
10-Q
10-Q

Quarterly report [Sections 13 or 15(d)]

Quarterly Reports

November 14, 2024
2024
SC 13G
SC 13G

Statement of acquisition of beneficial ownership by individuals

November 6, 2024
2024
SC 13G
SC 13G

Statement of acquisition of beneficial ownership by individuals

November 6, 2024
2024
SC 13G/A
SC 13G/A

Statement of acquisition of beneficial ownership by individuals - amendment

November 4, 2024
2024
SC 13G/A
SC 13G/A

Statement of acquisition of beneficial ownership by individuals - amendment

September 24, 2024
2024
NT 10-Q
NT 10-Q

Notification of inability to timely file Form 10-Q or 10-QSB

September 24, 2024
2024
10-Q
10-Q

Quarterly report [Sections 13 or 15(d)]

Quarterly Reports

August 16, 2024
2024
8-K
8-K

Current report

Current Reports

August 16, 2024
2024
SC 13G
SC 13G

Statement of acquisition of beneficial ownership by individuals

August 14, 2024
2024
8-K
8-K

Current report

Current Reports

August 13, 2024
2024
SC 13G
SC 13G

Statement of acquisition of beneficial ownership by individuals

August 12, 2024
2024
424B4
424B4

Prospectus [Rule 424(b)(4)]

August 8, 2024
2024
8-A12B
8-A12B

Registration of securities [Section 12(b)]

August 8, 2024
2024
CERT
CERT

*

August 8, 2024
2024
EFFECT
EFFECT

Notice of Effectiveness

August 6, 2024
2024
CORRESP
CORRESP

Correspondence

August 6, 2024
2024
CORRESP
CORRESP

Correspondence

July 30, 2024
2024
S-1/A
S-1/A

General form for registration of securities under the Securities Act of 1933 - amendment

July 12, 2024
2024
CORRESP
CORRESP

Correspondence

July 12, 2024
2024
S-1/A
S-1/A

General form for registration of securities under the Securities Act of 1933 - amendment

July 9, 2024
2024
UPLOAD
UPLOAD

SEC-generated letter

June 18, 2024
2024
S-1
S-1

General form for registration of securities under the Securities Act of 1933

April 5, 2024
2024
S-1
S-1

Correspondence

April 5, 2024
2024
DRS/A
DRS/A

Draft Registration Statement - amendment

March 22, 2024
2024
UPLOAD
UPLOAD

SEC-generated letter

February 23, 2024
2024
DRS/A
DRS/A

Draft Registration Statement - amendment

February 23, 2024
2024
CORRESP
CORRESP

Correspondence

February 15, 2024
2024
UPLOAD
UPLOAD

SEC-generated letter

January 18, 2024
2024
DRS
DRS

Draft Registration Statement

Management & Directors

Warren Hosseinion

M.D., Chairman

Oded Levy

Board Director

Adeel Rouf

President & CEO

Jonathan Intrater

Board Director

Alex Rogers

CFO

Warren Hosseinion Jr

VP of Mergers & Acquisitions

Warren Hosseinion

M.D., Chairman
  • Co-founder, former CEO/Board Director of Apollo Medical Holdings, Inc. (AMEH)
  • Chairman of Cardio Diagnostics, Inc. (NASDAQ: CDIO)
  • President & Board Director at Nutex Health, Inc. (NASDAQ: NUTX)
  • Chairman of Altitude Acquisition Corp. (NASDAQ: ALTU)
  • Former Chairman/CEO of Clinigence Holdings, Inc.
  • M.S. Physiology/Biophysics, Georgetown; M.D., Georgetown School of Medicine
  • Internal medicine residency, USC

Oded Levy

Board Director
  • Founder, President, and Managing Partner at Blue Ox Healthcare Partners
  • Over 30 years in healthcare investment, PE, and asset management
  • Board Director at Cardio Diagnostics, Inc. (NASDAQ: CDIO)
  • Former Principal at Oracle Partners, LP
  • Ex-Head Trader and Executive Committee member at Genesis Merchant Group Securities
  • Former SVP of Investments at Bering Holdings
  • MBA in Finance/International Business; BS in Computer/Information Systems, NYU

Adeel Rouf

President & CEO
  • Founder/CFO of SPAC merged with Rubicon Technologies, valued at $1.7 billion (NYSE: RBT)
  • Board Director at Zalatoris II Acquisition Corp (NASDAQ: ZLS) & Zalatoris Acquisition Corp. (NYSE: TCOA)
  • COO of Northern Revival Acquisition Corp
  • Former SVP at Altitude Acquisition Corp. (NASDAQ: ALTU)
  • Investment Professional at FinTech Acquisition Corp. III, leading to Paya Inc. merger (NASDAQ: PAYA)
  • BBA in accounting from Baruch College, M.S. in Sustainability Management and Energy Finance from Columbia University

Jonathan Intrater

Board Director
  • Managing Director at Ladenburg Thalmann & Co
  • Over 30 years in investment banking, handling $10+ billion transactions in PE, M&A, etc
  • Board member and Audit Committee Chairman, GreenVision Acquisition Corp., led business combination in 2021 (NASDAQ: GRNV)
  • CEO/Chairman of Mana Capital Acquisition Corp. (NASDAQ: MANA), completed merger with Cardio Diagnostics in 2022 (NASDAQ: CDIO)
  • Former Managing Director at Brenner Securities Corporation and SVP at BIA/Frazier, Gross & Kadlec
  • MBA from Vanderbilt University, Bachelor's from the University of Pennsylvania

Alex Rogers

CFO
  • Principal at Blue Ox Healthcare Partners
  • Over 15 years as alternative investment expert
  • Ex-Senior Director at MVision Private Equity Advsiors
  • Managed over $3 billion of co-investment by limited partners at First Reserve
  • Led launch of fund families at Performance Equity Management and managed co-investments at First Reserve
  • Grew private markets consulting at NEPC, overseeing due diligence, portfolio construction, and monitoring
  • BSBA in Finance and an MBA from D'Amore-McKim School of Business, Northeastern University

Warren Hosseinion Jr

VP of Mergers & Acquisitions
  • COO of Vesicor Therapeutics
  • Former executive and equity holder at a blockchain startup, leading strategy, operations, and marketing
  • B.S. in Biology from Pitzer College

Please check back soon for updates.

Governance Documents

Code Of Ethics
Compensation Committee Charter
Audit Committee Charter

Governance Documents

Code Of Ethics
Compensation Committee Charter
Audit Committee Charter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.